Tendyne Transcatheter Mitral Valve Shows Sustained Benefits at 2 Years Tendyne Transcatheter Mitral Valve Shows Sustained Benefits at 2 Years

More than 93% of patients had no mitral regurgitation at 2 years, but concerns were raised about rates of major bleeding and disabling stroke.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news